← Open Payments lookup

EMEKA MADU: Open Payments

NPI 1275003824 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,994 in 85 payments from 18 companies in 2025. Trend: 2023 $73 · 2024 $965 · 2025 $2,994

Food & beverage: $1,966Travel & lodging: $1,028
CompanyPaymentsAmount
Abbott Laboratories11$1,328
Merck Sharp & Dohme LLC8$212
Alnylam Pharmaceuticals Inc.4$207
Amgen Inc.14$154
Boehringer Ingelheim Pharmaceuticals, Inc.7$154
PFIZER INC.7$138
Novartis Pharmaceuticals Corporation5$119
E.R. Squibb & Sons, L.L.C.5$110
Bayer Healthcare Pharmaceuticals Inc.4$109
Actelion Pharmaceuticals US, Inc.5$108

Products named: CARDIOMEMS, AMVUTTRA, REPATHA, JARDIANCE, WINREVAIR, ELIQUIS, LEQVIO, Kerendia.

Industry payments across NV — which companies pay providers there.